Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Novo Nordisk parent’s huge manufacturing deal is one step closer to closing. Meanwhile, Nobel Prize winners urge senators to ...
Zacks.com on MSN4h
Eli Lilly Reports Positive Data From Late-Stage Breast Cancer Study
Eli Lilly LLY announced results from the phase III EMBER-3 study, which showed that treatment with its orally administered ...
Science News23h
The benefits of Ozempic and its kin may extend far beyond weight loss
Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.
AI Alarabiya23h
GCC childhood obesity crisis fuels debate on GLP-1 weight-loss drug use for minors
The childhood obesity epidemic in GCC countries has triggered a debate on the potential use of weight-loss medications such ...